Report Summary

Datamonitor's MediPal Holdings Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. MediPal Holdings Corporation - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

MediPal Holdings (formerly Mediceo Paltac Holdings) is a Japan-based company engaged in the wholesale distribution of prescription pharmaceuticals, cosmetics, daily necessities, and over-the-counter pharmaceuticals. It is also involved in the sale of industrial chemicals and food additives. The company primarily operates in Japan. It is headquartered in Tokyo, Japan and employed 11,363 people as of March 2010. The company recorded revenues of JPY2,546,029 million (approximately $27,446.2 million) during the financial year (FY) ended March 2010, an increase of 3.3% over FY2009. The operating profit of the company was JPY18,433 million (approximately $198.7 million) during FY2010, an increase of 37% over FY2009. The net profit of the company was JPY1,958 million (approximately $21.1 million) in FY2010, a decrease of 84.3% over FY2009.

Scope of the Report

• Provides all the crucial information on MediPal Holdings Corporation required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting MediPal Holdings Corporation in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of MediPal Holdings Corporation
• Data is supplemented with details on MediPal Holdings Corporation history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from MediPal Holdings Corporation

Reasons to Purchase

• Support sales activities by understanding your customers’ businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors’ business structure, strategy and prospects
• Obtain the most up to date company information available